• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov6
Canaccord Genuity Analyst Reiterates Buy Rating on Seres Therapeutics Stock
14:52
Nov5
Seres Therap released FY2025 9 Months Earnings on November 5 During-Market EST, actual revenue USD 351K, actual EPS USD 2.4159
21:00
Seres Therap released FY2025 Q3 earnings during market hours on November 5 (EST), actual revenue USD 351 K (forecast USD 5.875 M), actual EPS USD 0.9366 (forecast USD 0.425)
21:00
Oct29
Seres Therap to Release FY2025 Q3 Earnings on November 5 During-Market EST, Forecast Revenue USD 5.875 M, EPS USD 0.425
00:05
Aug6
Seres Therap released FY2025 Q2 earnings during market hours on August 6 (EST), with actual revenue of USD 0 (forecast USD 0) and actual EPS of USD -2.2707 (forecast USD -2.49)
20:00
Seres Therap released FY2025 Semi-Annual Earnings on August 6 During-Market EST, actual revenue USD 0, actual EPS USD 1.47
20:00

Schedules & Filings

Schedules
Filings
Nov5
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 351 K, Net Income 8.204 M, EPS 0.9366

Aug6
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -19.86 M, EPS -2.2707

May7
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income 32.68 M, EPS 3.75

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
BBGI
16.690
+312.10%
+12.640
SRV.RT
0.0900
+111.76%
+0.048
BEAT
1.550
+92.43%
+0.745
ENVB
10.330
+74.49%
+4.410
BDRX
6.720
+65.11%
+2.650
ASPC
16.810
+60.40%
+6.330
IRBT
5.240
+48.44%
+1.710
CGTL
0.9727
+47.40%
+0.313
MIGI
6.700
+45.65%
+2.100
PLAB
37.350
+45.39%
+11.660
View More